{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:21:02Z","timestamp":1792102862069,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY026177"],"award-info":[{"award-number":["EY026177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY034238"],"award-info":[{"award-number":["EY034238"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000950","name":"Alcon Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY034333"],"award-info":[{"award-number":["EY034333"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtm.2025.101614","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:57:25Z","timestamp":1760223445000},"page":"101614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Sam","family":"Yacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasankara Reddy","family":"Kaipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarahi","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Kasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhavathi","family":"Maddineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbot F.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9472-9373","authenticated-orcid":false,"given":"Gulab S.","family":"Zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101614_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","article-title":"Neuronal death in glaucoma","volume":"18","author":"Quigley","year":"1999","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2025.101614_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0161-6420(83)34492-4","article-title":"Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations","volume":"90","author":"Rohen","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2025.101614_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/bs.pmbts.2015.06.007","article-title":"Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways","volume":"134","author":"Tamm","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archopht.1997.01100150377011","article-title":"Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids","volume":"115","author":"Johnson","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtm.2025.101614_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exer.2016.07.009","article-title":"The many faces of the trabecular meshwork cell","volume":"158","author":"Stamer","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exer.2014.07.014","article-title":"Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma","volume":"133","author":"Vranka","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2008.11.008","article-title":"Mechanobiology of trabecular meshwork cells","volume":"88","author":"WuDunn","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00417-008-0800-0","article-title":"Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma","volume":"246","author":"Tawara","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omtm.2025.101614_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.exer.2009.02.007","article-title":"The trabecular meshwork outflow pathways: structural and functional aspects","volume":"88","author":"Tamm","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000310782","article-title":"Trabecular meshwork phagocytosis in glaucomatous eyes","volume":"211","author":"Matsumoto","year":"1997","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.omtm.2025.101614_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0161-6420(84)34248-8","article-title":"Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals","volume":"91","author":"Alvarado","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2025.101614_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrrev.2005.11.001","article-title":"The role of oxidative stress in glaucoma","volume":"612","author":"Izzotti","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.omtm.2025.101614_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.exer.2008.11.003","article-title":"The genetics of primary open-angle glaucoma: a review","volume":"88","author":"Allingham","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamaophthalmol.2019.0005","article-title":"Myocilin Mutations in Patients With Normal-Tension Glaucoma","volume":"137","author":"Alward","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omtm.2025.101614_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0039-6257(02)00353-3","article-title":"Myocilin glaucoma","volume":"47","author":"Fingert","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.omtm.2025.101614_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.genom.6.080604.162209","article-title":"Complex genetics of glaucoma susceptibility","volume":"6","author":"Libby","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101614_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1350-9462(02)00010-1","article-title":"Myocilin and glaucoma: facts and ideas","volume":"21","author":"Tamm","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.275.5300.668","article-title":"Identification of a gene that causes primary open angle glaucoma","volume":"275","author":"Stone","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101614_bib20","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/6.12.2091","article-title":"Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma","volume":"6","author":"Adam","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101614_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(97)00934-4","article-title":"Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin","volume":"413","author":"Ortego","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2025.101614_bib22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101614_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2353\/ajpath.2007.060806","article-title":"Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma","volume":"170","author":"Yam","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2025.101614_bib24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1167\/iovs.06-0943","article-title":"Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis","volume":"48","author":"Yam","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib25","first-page":"618","article-title":"Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells","volume":"13","author":"Wang","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.omtm.2025.101614_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/hmg\/ddh128","article-title":"Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma","volume":"13","author":"Liu","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101614_bib27","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma","volume":"121","author":"Zode","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101614_bib28","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1167\/iovs.11-8837","article-title":"Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma","volume":"53","author":"Zode","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143359","article-title":"Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin","volume":"6","author":"Kasetti","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101614_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188710","article-title":"Impaired axonal transport contributes to neurodegeneration in a Cre-inducible mouse model of myocilin-associated glaucoma","volume":"10","author":"Kaipa","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101614_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101188","article-title":"Myocilin misfolding and glaucoma: A 20-year update","volume":"95","author":"Saccuzzo","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/bbrc.1998.8917","article-title":"Mouse myocilin (Myoc) gene expression in ocular tissues","volume":"248","author":"Takahashi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2025.101614_bib33","first-page":"3420","article-title":"Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization","volume":"41","author":"Swiderski","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-1549(03)00068-3","article-title":"Current perspectives on the TIGR\/MYOC gene (Myocilin) and glaucoma","volume":"16","author":"Polansky","year":"2003","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.omtm.2025.101614_bib35","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1128\/MCB.21.22.7707-7713.2001","article-title":"Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function","volume":"21","author":"Kim","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101614_bib36","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1128\/MCB.01127-06","article-title":"Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma","volume":"26","author":"Gould","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101614_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/1203","article-title":"Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma","volume":"19","author":"Morissette","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2025.101614_bib38","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 Structures and Mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.omtm.2025.101614_bib40","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1111\/febs.16771","article-title":"Therapeutic applications of CRISPR\/Cas9 gene editing technology for the treatment of ocular diseases","volume":"290","author":"Sundaresan","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.omtm.2025.101614_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1292452","article-title":"Current trends of clinical trials involving CRISPR\/Cas systems","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.omtm.2025.101614_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ahg.12271","article-title":"CRISPR-Cas9: A cornerstone for the evolution of precision medicine","volume":"82","author":"Razzouk","year":"2018","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101614_bib43","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2025.101614_bib44","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1038\/s41598-024-57286-6","article-title":"Lentiviral mediated delivery of CRISPR\/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma","volume":"14","author":"Patil","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101614_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15464","article-title":"CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101614_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1186\/s12864-017-4225-1","article-title":"Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm","volume":"18","author":"Zhou","year":"2017","journal-title":"BMC Genom."},{"key":"10.1016\/j.omtm.2025.101614_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101614_bib48","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.biomaterials.2014.05.032","article-title":"Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo","volume":"35","author":"Gyorgy","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2025.101614_bib49","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1073\/pnas.87.6.2211","article-title":"Site-specific integration by adeno-associated virus","volume":"87","author":"Kotin","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307796121","article-title":"Targeted nonviral delivery of genome editors in vivo","volume":"121","author":"Tsuchida","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib51","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101614_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210104119","article-title":"Precision genome editing in the eye","volume":"119","author":"Suh","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101614_bib54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jconrel.2025.01.068","article-title":"Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye","volume":"379","author":"Vasudevan","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101614_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib56","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101614_bib57","article-title":"Nanomaterial Delivery Systems for mRNA Vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtm.2025.101614_bib58","first-page":"424","article-title":"Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway","volume":"33","author":"de Kater","year":"1992","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib59","first-page":"2561","article-title":"Contractile markers distinguish structures of the mouse aqueous drainage tract","volume":"19","author":"Ko","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.omtm.2025.101614_bib60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exer.2010.08.005","article-title":"Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma","volume":"93","author":"Morrison","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archopht.1981.03930010139020","article-title":"Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtm.2025.101614_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/toxsci\/kfw220","article-title":"Viral Vectors: The Road to Reducing Genotoxicity","volume":"155","author":"David","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtm.2025.101614_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtm.2025.101614_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jbiotec.2016.06.011","article-title":"Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing","volume":"233","author":"Kelley","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101614_bib66","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.5625\/lar.2018.34.4.147","article-title":"Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes","volume":"34","author":"Kim","year":"2018","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.omtm.2025.101614_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092845","article-title":"Cellular processing of myocilin","volume":"9","author":"Qiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101614_bib68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","article-title":"A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtm.2025.101614_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101614_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtm.2025.101614_bib71","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101614_bib72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101614_bib73","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13311-022-01197-9","article-title":"CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy","volume":"19","author":"Mbakam","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtm.2025.101614_bib74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101614_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exer.2015.04.003","article-title":"Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork","volume":"141","author":"Pang","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2025.101614_bib76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-0716-3409-7_9","article-title":"Viral Vector-Induced Ocular Hypertension in Mice","volume":"2708","author":"Millar","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101614_bib77","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1038\/s41467-020-19352-1","article-title":"ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load","volume":"11","author":"Kasetti","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101614_bib78","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1167\/iovs.09-4567","article-title":"Adenoviral Gene Transfer of Active Human Transforming Growth Factor-{beta}2 Elevates Intraocular Pressure and Reduces Outflow Facility in Rodent Eyes","volume":"51","author":"Shepard","year":"2010","journal-title":"Invest Ophth Vis Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031521","article-title":"Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model","volume":"25","author":"Mokady","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib80","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1167\/iovs.14-16220","article-title":"Increased Endoplasmic Reticulum Stress in Human Glaucomatous Trabecular Meshwork Cells and Tissues","volume":"56","author":"Peters","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2025.101614_bib81","first-page":"6058","article-title":"Expression of Mutant Myocilin Induces Abnormal Intracellular Accumulation of Selected Extracellular Matrix Proteins in the Trabecular Meshwork","volume":"57","author":"Kasetti","year":"2016","journal-title":"IOVS"},{"key":"10.1016\/j.omtm.2025.101614_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-020-00400-9","article-title":"CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma","volume":"15","author":"Maddineni","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2025.101614_bib83","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022461118","article-title":"Impaired TRPV4-eNOS signaling in trabecular meshwork elevates intraocular pressure in glaucoma","volume":"118","author":"Patel","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101614_bib84","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omtm.2025.101614_bib85","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI69774","article-title":"Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma","volume":"124","author":"Zode","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101614_bib86","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1074\/jbc.RA118.002540","article-title":"Transforming growth factor \u03b22 (TGF\u03b22) signaling plays a key role in glucocorticoid-induced ocular hypertension","volume":"293","author":"Kasetti","year":"2018","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:28:01Z","timestamp":1776198481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2329050125002098"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101614","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101614"}}